Harrington, Lucas B.
Paez-Espino, David http://orcid.org/0000-0002-2939-5398
Staahl, Brett T.
Chen, Janice S.
Ma, Enbo
Kyrpides, Nikos C.
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
Article History
Received: 16 May 2017
Accepted: 14 September 2017
First Online: 10 November 2017
Competing interests
: J.A.D. is executive director of the Innovative Genomics Institute at the University of California, Berkeley (UC Berkeley) and the University of California, San Francisco (UCSF). J.A.D. is a co-founder of Editas Medicine, Intellia Therapeutics and Caribou Biosciences and a scientific adviser to Caribou, Intellia, eFFECTOR Therapeutics and Driver. UC Berkeley and HHMI have patents pending for CRISPR technologies on which the authors are inventors. The remaining authors declare no competing financial interests.